ASCO 2019 | mBCa: choosing the best treatment

Hannah Linden

Hannah Linden, MD, FACP, of the Seattle Cancer Care Alliance, Seattle, WA, discusses difficulties in choosing the best treatment option for metastatic breast cancer (mBCa). This interview was recorded at the American Society of Oncology (ASCO) 2019 Annual Meeting, held in Chicago, IL.

Share this video